Apollo Hospitals shareholders approved all eight resolutions proposed at its 45th Annual General Meeting held on August 25, 2026. The meeting, conducted via video conference, saw strong support for the adoption of financial statements for FY26 and the declaration of final dividends.

Governance and Leadership Renewals

The meeting focused significantly on board composition and leadership continuity. Shareholders voted to reappoint Dr. Prathap C Reddy as Executive Chairman for a further two-year term effective from June 25, 2026. This special resolution received 96.98% support from votes polled. Additionally, Smt. Sangita Reddy was reappointed as a director upon retirement by rotation, securing 96.72% of votes cast.

Independent director Smt. Rama Bijapurkar was also reappointed for a five-year term commencing November 12, 2026. Her reappointment garnered 98.67% approval, reflecting continued confidence in the independent oversight structure of the board.

Capital Structure and Debt Authorization

A key strategic outcome was the approval to raise capital through non-convertible debentures. Shareholders authorized the company to offer or invite subscriptions for secured or unsecured redeemable non-convertible debentures aggregating up to ₹7,500 million on a private placement basis. This special resolution passed with 98.87% affirmative votes, providing the company with flexibility to manage its capital structure and fund future expansion plans without diluting equity.

Financial Statements and Dividends

The ordinary resolution to adopt the audited standalone and consolidated financial statements for the year ended March 31, 2026, passed with near-unanimous support (99.99%). The statutory and secretarial auditors’ reports were free from qualifications.

Shareholders also confirmed the payment of interim dividends and declared final dividends on equity shares for FY26. This resolution secured 99.97% approval, underscoring shareholder alignment with the company’s dividend policy.

Voting Participation

As of the record date, August 18, 2026, the company had 173,384 shareholders. A total of 1,712 members participated in e-voting for the financial statements resolution, representing over 123.8 million shares. The promoter group voted in favor of all resolutions, while public institutional investors showed varying levels of dissent on leadership-related items, though all proposals ultimately passed comfortably.

What the Numbers Show

While the promoter group maintained 100% support across all resolutions, public institutional investors registered measurable dissent on the reappointment of Dr. Prathap C Reddy as Executive Chairman, with approximately 4.5% of their votes cast against the proposal. Despite this, the overwhelming majority of votes polled favored the leadership continuity, indicating broad-based acceptance of the management’s direction.

Apollo Hospitals stated during a concall that its hospital business is on track to deliver close to 20% revenue growth for the full year. The update signals sustained operational momentum within the company's core hospital segment.

Hospital business growth guidance

Apollo Hospitals indicated that the hospital business is progressing in line with expectations, with full-year revenue growth anticipated to come in close to 20%. The guidance was shared as part of a concall update, underscoring management's confidence in the segment's trajectory.

The hospital segment remains the primary growth driver highlighted by management in this update. No additional financial metrics or segment-level breakdowns were disclosed as part of this concall communication.